HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica

We examined factors associated with high-grade squamous intraepithelial lesions (HSIL) and cervical cancer among human papillomavirus (HPV)-infected women in a prevalent case–control study conducted within a population-based cohort of 10 077 women in Costa Rica. We compared 146 women with HPV-positive HSIL or cancer (HSIL/CA) against 843 HPV-positive women without evidence of HSIL/CA. Subjects completed a risk factor questionnaire. We evaluated the associations between exposures and HSIL/CA among women positive for any HPV and restricted to those positive for high-risk HPV types. Risk of HSIL/CA increased with increasing number of live births (Ptrend= 0.04). Women who smoked 6+ cigarettes/day had a RR for HSIL/CA of 2.7 (95% CI = 1.1–6.7) compared to non-smokers. Current use of barrier contraceptives was associated with a reduction in risk of HSIL/CA (RR = 0.39; 95% CI = 0.16–0.96). Sexual behaviour and a self-reported history of sexually transmitted diseases (STDs) other than HPV were not associated with HSIL/CA. Oral contraceptive use was associated with HSIL/CA among women with <3 pregnancies. Effects were similar in analysis restricted to women positive for high-risk HPV types. Among women positive for high-risk HPV types, 44% of HSIL/CA could be attributed to multiparity (≥3 pregnancies) and/or smoking. Among HPV-positive women, multiparity and smoking are risk factors for HSIL/CA. Oral contraceptive use may be associated with HSIL/CA in subgroups of women. © 2001 Cancer Research Campaign http://www.bjcancer.com

Abstract licence: CC BY-NC-SA

1. 1.

   Arbeit J. M., Howley P. M., Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A. 1996;93(7):2930-2935.

   Not in our library10.1073/pnas.93.7.2930 (opens in a new tab)

2. 2.

   Bartholomew J. S., Glenville S., Sarkar S., Burt D. J., Stanley M. A., Ruiz-Cabello F., Chengang J., Garrido F., Stern P. L. Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells. Cancer Res. 1997;57(5):937-942.

   Not in our library

3. 3.

   Becker T. M., Wheeler C. M., McGough N. S., Stidley C. A., Parmenter C. A., Dorin M. H., Jordan S. W. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women. Int J Epidemiol. 1994;23(5):913-922.

   Not in our library10.1093/ije/23.5.913 (opens in a new tab)

4. 4.

   Benichou J., Gail M. H. Variance calculations and confidence intervals for estimates of the attributable risk based on logistic models. Biometrics. 1990;46(4):991-1003.

   Not in our library

5. 5.

   Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87(11):796-802.

   Not in our library10.1093/jnci/87.11.796 (opens in a new tab)

6. 6.

   Bosch F. X., Muñoz N., de Sanjosé S., Izarzugaza I., Gili M., Viladiu P., Tormo M. J., Moreo P., Ascunce N., Gonzalez L. C. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992;52(5):750-758.

   Not in our library10.1002/ijc.2910520514 (opens in a new tab)

7. 7.

   Chaouki N., Bosch F. X., Muñoz N., Meijer C. J., El Gueddari B., El Ghazi A., Deacon J., Castellsagué X., Walboomers J. M. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer. 1998;75(4):546-554.

   Not in our library10.1002/(sici)1097-0215(19980209)75:4<546::aid-ijc9>3.0.co;2-t (opens in a new tab)

8. 8.

   Chichareon S., Herrero R., Muñoz N., Bosch F. X., Jacobs M. V., Deacon J., Santamaria M., Chongsuvivatwong V., Meijer C. J., Walboomers J. M. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst. 1998;90(1):50-57.

   Not in our library10.1093/jnci/90.1.50 (opens in a new tab)

9. 9.

   Cox J. T., Lorincz A. T., Schiffman M. H., Sherman M. E., Cullen A., Kurman R. J. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995;172(3):946-954.

   Not in our library10.1016/0002-9378(95)90026-8 (opens in a new tab)

10. 10.

    Fife K. H., Katz B. P., Brizendine E. J., Brown D. R. Cervical human papillomavirus deoxyribonucleic acid persists throughout pregnancy and decreases in the postpartum period. Am J Obstet Gynecol. 1999;180(5):1110-1114.

    Not in our library10.1016/s0002-9378(99)70602-2 (opens in a new tab)

11. 11.

    Fife K. H., Rogers R. E., Zwickl B. W. Symptomatic and asymptomatic cervical infections with human papillomavirus during pregnancy. J Infect Dis. 1987;156(6):904-911.

    Not in our library10.1093/infdis/156.6.904 (opens in a new tab)

12. 12.

    Geng Y., Savage S. M., Razani-Boroujerdi S., Sopori M. L. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol. 1996;156(7):2384-2390.

    Not in our library

13. 13.

    Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri · 1980

14. 14.

    Herrero R., Brinton L. A., Reeves W. C., Brenes M. M., de Britton R. C., Tenorio F., Gaitan E. Injectable contraceptives and risk of invasive cervical cancer: evidence of an association. Int J Cancer. 1990;46(1):5-7.

    Not in our library10.1002/ijc.2910460103 (opens in a new tab)

15. 15.

    Herrero R., Hildesheim A., Bratti C., Sherman M. E., Hutchinson M., Morales J., Balmaceda I., Greenberg M. D., Alfaro M., Burk R. D. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92(6):464-474.

    Not in our library10.1093/jnci/92.6.464 (opens in a new tab)

16. 16.

    Herrero R., Schiffman M. H., Bratti C., Hildesheim A., Balmaceda I., Sherman M. E., Greenberg M., Cárdenas F., Gómez V., Helgesen K. Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica. 1997;1(5):362-375.

    Not in our library10.1590/s1020-49891997000500005 (opens in a new tab)

17. 17.

    Hildesheim A., Schiffman M. H., Gravitt P. E., Glass A. G., Greer C. E., Zhang T., Scott D. R., Rush B. B., Lawler P., Sherman M. E. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994;169(2):235-240.

    Not in our library10.1093/infdis/169.2.235 (opens in a new tab)

18. 18.

    Ho G. Y., Kadish A. S., Burk R. D., Basu J., Palan P. R., Mikhail M., Romney S. L. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer. 1998;78(3):281-285.

    Not in our library10.1002/(sici)1097-0215(19981029)78:3<281::aid-ijc3>3.0.co;2-r (opens in a new tab)

19. 19.

    Johnson J. D., Houchens D. P., Kluwe W. M., Craig D. K., Fisher G. L. Effects of mainstream and environmental tobacco smoke on the immune system in animals and humans: a review. Crit Rev Toxicol. 1990;20(5):369-395.

    Not in our library10.3109/10408449009089870 (opens in a new tab)

20. 20.

    Kjaer S. K., van den Brule A. J., Bock J. E., Poll P. A., Engholm G., Sherman M. E., Walboomers J. M., Meijer C. J. Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer. 1996;65(5):601-606.

    Not in our library10.1002/(sici)1097-0215(19960301)65:5<601::aid-ijc8>3.0.co;2-6 (opens in a new tab)

21. 21.

    Krüger-Kjaer S., van den Brule A. J., Svare E. I., Engholm G., Sherman M. E., Poll P. A., Walboomers J. M., Bock J. E., Meijer C. J. Different risk factor patterns for high-grade and low-grade intraepithelial lesions on the cervix among HPV-positive and HPV-negative young women. Int J Cancer. 1998;76(5):613-619.

    Not in our library10.1002/(sici)1097-0215(19980529)76:5<613::aid-ijc1>3.0.co;2-t (opens in a new tab)

22. 22.

    Mitrani-Rosenbaum S., Tsvieli R., Tur-Kaspa R. Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol. 1989;70(Pt 8):2227-2232.

    Not in our library10.1099/0022-1317-70-8-2227 (opens in a new tab)

23. 23.

    Mittal R., Tsutsumi K., Pater A., Pater M. M. Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones. Obstet Gynecol. 1993;81(1):5-12.

    Not in our library

24. 24.

    Moreno V., Muñoz N., Bosch F. X., de Sanjosé S., Gonzalez L. C., Tafur L., Gili M., Izarzugaza I., Navarro C., Vergara A. Risk factors for progression of cervical intraepithelial neoplasm grade III to invasive cervical cancer. Cancer Epidemiol Biomarkers Prev. 1995;4(5):459-467.

    Not in our library

25. 25.

    Muñoz N., Bosch F. X., de Sanjosé S., Vergara A., del Moral A., Muñoz M. T., Tafur L., Gili M., Izarzugaza I., Viladiu P. Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomarkers Prev. 1993;2(5):423-431.

    Not in our library

26. 26.

    Ngelangel C., Muñoz N., Bosch F. X., Limson G. M., Festin M. R., Deacon J., Jacobs M. V., Santamaria M., Meijer C. J., Walboomers J. M. Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst. 1998;90(1):43-49.

    Not in our library10.1093/jnci/90.1.43 (opens in a new tab)

27. 27.

    Nobbenhuis M. A., Walboomers J. M., Helmerhorst T. J., Rozendaal L., Remmink A. J., Risse E. K., van der Linden H. C., Voorhorst F. J., Kenemans P., Meijer C. J. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet. 1999;354(9172):20-25.

    Not in our library10.1016/s0140-6736(98)12490-x (opens in a new tab)

28. 28.

    Olsen A. O., Dillner J., Skrondal A., Magnus P. Combined effect of smoking and human papillomavirus type 16 infection in cervical carcinogenesis. Epidemiology. 1998;9(3):346-349.

    Not in our library

29. 29.

    Pater M. M., Hughes G. A., Hyslop D. E., Nakshatri H., Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature. 1988;335(6193):832-835.

    Not in our library10.1038/335832a0 (opens in a new tab)

30. 30.

    Prokopczyk B., Cox J. E., Hoffmann D., Waggoner S. E. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J Natl Cancer Inst. 1997;89(12):868-873.

    Not in our library10.1093/jnci/89.12.868 (opens in a new tab)

31. 31.

    Rando R. F., Lindheim S., Hasty L., Sedlacek T. V., Woodland M., Eder C. Increased frequency of detection of human papillomavirus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol. 1989;161(1):50-55.

    Not in our library10.1016/0002-9378(89)90231-7 (opens in a new tab)

32. 32.

    Reeves W. C., Caussy D., Brinton L. A., Brenes M. M., Montalvan P., Gomez B., de Britton R. C., Morice E., Gaitan E., de Lao S. L. Case-control study of human papillomaviruses and cervical cancer in Latin America. Int J Cancer. 1987;40(4):450-454.

    Not in our library10.1002/ijc.2910400403 (opens in a new tab)

33. 33.

    Roteli-Martins C. M., Panetta K., Alves V. A., Siqueira S. A., Syrjänen K. J., Derchain S. F. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand. 1998;77(6):678-682.

    Not in our library10.1034/j.1600-0412.1998.770617.x (opens in a new tab)

34. 34.

    Schiffman M. H., Bauer H. M., Hoover R. N., Glass A. G., Cadell D. M., Rush B. B., Scott D. R., Sherman M. E., Kurman R. J., Wacholder S. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85(12):958-964.

    Not in our library10.1093/jnci/85.12.958 (opens in a new tab)

35. 35.

    Schiffman M. H., Brinton L. A. The epidemiology of cervical carcinogenesis. Cancer. 1995;76(10 Suppl):1888-1901.

    Not in our library10.1002/1097-0142(19951115)76:10+<1888::aid-cncr2820761305>3.0.co;2-h (opens in a new tab)

36. 36.

    Schiffman M., Herrero R., Hildesheim A., Sherman M. E., Bratti M., Wacholder S., Alfaro M., Hutchinson M., Morales J., Greenberg M. D. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA. 2000;283(1):87-93.

    Not in our library10.1001/jama.283.1.87 (opens in a new tab)

37. 37.

    Schneider A., Hotz M., Gissmann L. Increased prevalence of human papillomaviruses in the lower genital tract of pregnant women. Int J Cancer. 1987;40(2):198-201.

    Not in our library10.1002/ijc.2910400212 (opens in a new tab)

38. 38.

    Smith E. M., Johnson S. R., Jiang D., Zaleski S., Lynch C. F., Brundage S., Anderson R. D., Turek L. P. The association between pregnancy and human papilloma virus prevalence. Cancer Detect Prev. 1991;15(5):397-402.

    Not in our library

• Factors associated with high-risk human papillomavirus infection and high-grade cervical neoplasia: A population-based study in Paraguay. · 2019

  Not checked

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.